c-Myc modulation: a key role in melanoma drug response.

about

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.Role of DHX33 in c-Myc-induced cancers.Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.

P2860

Q33605879-739E8735-AA81-496B-8CF3-15870C3D03FF Q42509683-1FF0AA92-221A-4D92-BA74-BD0E29088A68 Q44637964-2FFBDFF9-3A3E-4A61-B635-BE95E065B92A

P2860

c-Myc modulation: a key role in melanoma drug response.

Item

http://www.wikidata.org/entity/Q36213103

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

c-Myc modulation: a key role in melanoma drug response.

@ast

c-Myc modulation: a key role in melanoma drug response.

@en

type

Item

label

c-Myc modulation: a key role in melanoma drug response.

@ast

c-Myc modulation: a key role in melanoma drug response.

@en

prefLabel

c-Myc modulation: a key role in melanoma drug response.

@ast

c-Myc modulation: a key role in melanoma drug response.

@en

P1476

c-Myc modulation: a key role in melanoma drug response.

@en

P2093

Anna Valentino

http://www.w3.org/2001/XMLSchema#string

Annalisa Fico

http://www.w3.org/2001/XMLSchema#string

Daniela Alfano

http://www.w3.org/2001/XMLSchema#string

Ernesta Cavalcanti

http://www.w3.org/2001/XMLSchema#string

Salvatore Travali

http://www.w3.org/2001/XMLSchema#string

Valeria Vasta

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Mutations of the BRAF gene in human cancer

COX inhibitors and breast cancer

Mammalian MAP kinase signalling cascades

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway

Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set

Identification of cytotoxic drugs that selectively target tumor cells with MYC overexpression

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

P304

1375-1386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384047.2015.1030546

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo J Patriarca

Emilia Caputo

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274396768

http://www.w3.org/2001/XMLSchema#string

P698

25835050

http://www.w3.org/2001/XMLSchema#string

P932

4622542

http://www.w3.org/2001/XMLSchema#string

c-Myc modulation: a key role in melanoma drug response.

about

P2860

P2860

c-Myc modulation: a key role in melanoma drug response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932